Aristotle (ARTL) Prices $6.6M Share Upsized Common Offering

Go back to Aristotle (ARTL) Prices $6.6M Share Upsized Common Offering

Artelo Biosciences, Inc. Announces Pricing of $6.6 Million Upsized Underwritten Public Offering

October 9, 2020 8:30 AM UTC

LA JOLLA, Calif., Oct. 09, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on developing and commercializing treatments intended to modulate endogenous signaling pathways, including the endocannabinoid system, today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $6.6 million prior to deducting underwriting discounts and commissions and offering expenses payable by Artelo Biosciences, Inc.

The offering is comprised of 8.8 million units, priced at a public offering price of $0.75 per unit, with... More